BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1644897)

  • 1. Pavlovian conditioning of morphine-induced alterations of immune status.
    Coussons ME; Dykstra LA; Lysle DT
    J Neuroimmunol; 1992 Aug; 39(3):219-30. PubMed ID: 1644897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement.
    Coussons-Read ME; Dykstra LA; Lysle DT
    J Neuroimmunol; 1994 Dec; 55(2):135-42. PubMed ID: 7829663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral beta-adrenergic receptor involvement.
    Coussons-Read ME; Dykstra LA; Lysle DT
    Brain Behav Immun; 1994 Sep; 8(3):204-17. PubMed ID: 7865892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
    Saurer TB; Ijames SG; Carrigan KA; Lysle DT
    Brain Behav Immun; 2008 Jan; 22(1):89-97. PubMed ID: 17689049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine.
    Fecho K; Maslonek KA; Dykstra LA; Lysle DT
    Brain Behav Immun; 1993 Sep; 7(3):253-70. PubMed ID: 8219413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
    Lysle DT; Coussons ME; Watts VJ; Bennett EH; Dykstra LA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1071-8. PubMed ID: 7685383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance development to morphine-induced alterations of immune status.
    West JP; Lysle DT; Dykstra LA
    Drug Alcohol Depend; 1997 Jul; 46(3):147-57. PubMed ID: 9250473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the time course of morphine's analgesic and immunologic effects.
    Nelson CJ; Dykstra LA; Lysle DT
    Anesth Analg; 1997 Sep; 85(3):620-6. PubMed ID: 9296419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholinesterase monoclonal antibody-induced sympathectomy: effects on immune status and acute morphine-induced immunomodulation.
    Fecho K; Maslonek KA; Dykstra LA; Lysle DT
    Brain Behav Immun; 1997 Sep; 11(3):167-84. PubMed ID: 9417803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats.
    Fecho K; Maslonek KA; Dykstra LA; Lysle DT
    J Pharmacol Exp Ther; 1996 Feb; 276(2):626-36. PubMed ID: 8632330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute morphine treatment alters cellular immune function in the lungs of healthy rats.
    Coussons-Read ME; Giese S
    Int Immunopharmacol; 2001 Aug; 1(8):1571-81. PubMed ID: 11515820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological manipulation of immune alterations induced by an aversive conditioned stimulus: evidence for a beta-adrenergic receptor-mediated Pavlovian conditioning process.
    Lysle DT; Cunnick JE; Maslonek KA
    Behav Neurosci; 1991 Jun; 105(3):443-9. PubMed ID: 1650562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression.
    Gomez-Flores R; Weber RJ
    J Interferon Cytokine Res; 1999 Jun; 19(6):625-30. PubMed ID: 10433363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat.
    Fecho K; Lysle DT
    Cell Immunol; 1999 Aug; 195(2):137-46. PubMed ID: 10448013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of morphine conditioned behavior by an anti-dopaminergic post-trial drug treatment during re-consolidation.
    Leite Junior JB; de Mello Bastos JM; Samuels RI; Carey RJ; Carrera MP
    Behav Brain Res; 2019 Feb; 359():771-782. PubMed ID: 30114434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential tolerance to morphine's immunomodulatory effects following continuous administration.
    West JP; Dykstra LA; Lysle DT
    Drug Alcohol Depend; 1998 Dec; 53(1):31-8. PubMed ID: 10933338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine administered post-trial induces potent morphine conditioned effects if the context is novel but not if the context is familiar.
    Ferreira JS; de Mello Bastos JM; Leite Junior JB; Samuels RI; Carey RJ; Carrera MP
    Pharmacol Biochem Behav; 2020 Sep; 196():172978. PubMed ID: 32593788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT.
    Saurer TB; Carrigan KA; Ijames SG; Lysle DT
    J Neuroimmunol; 2004 Mar; 148(1-2):54-62. PubMed ID: 14975586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status.
    Lysle DT; Hoffman KE; Dykstra LA
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1533-40. PubMed ID: 8667220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism.
    Bayer BM; Daussin S; Hernandez M; Irvin L
    Neuropharmacology; 1990 Apr; 29(4):369-74. PubMed ID: 2160624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.